Aurinia Pharmaceuticals

AUPH(Aurinia Pharmaceuticals)

$16.87+3.75%

AUPH(Aurinia Pharmaceuticals) Price Prediction Summary

AI-Generated
As of October 8, 2026, AUPH is currently trading in the 16.00–16.32 range with technical indicators tilting bearish. MACD\'s sell signal combined with price positioning below the 20-day moving average points to momentum erosion, though the 200-day SMA at 15.55 provides a safety net. RSI neutrality suggests the market is neither capitulating nor overheating, leaving room for either consolidation or a test of support. Key uncertainty: sentiment and structural data are absent, limiting visibility into fund flows, institutional positioning, and broader market conviction. Watch the 16.00 level closely—a break below invites a retest of the 50-day SMA, while a hold above 16.32 could signal a temporary stabilization.
Technical Indicators
Momentum Weakening

Daily structure is fragile with negative MACD divergence and price hovering near key moving averages.

Key Trading Levels

How Gate Predicts AUPH(Aurinia Pharmaceuticals) Price

Multi-Source Data Collection

Three independent data sources—technical indicators, market sentiment, and market structure signals—are integrated in real time, covering price behavior, trader behavior, and supply-demand dynamics, ensuring the analysis does not rely on a single dimension.

Independent Analysis by Dimension

Technical indicators are used to identify trends and structural positions, market sentiment is used to assess risk appetite, and market structure signals are used to identify supply-demand and positioning changes. Each dimension independently generates signals within its most appropriate time frame.

Cross-Validation of Composite Signals

When signals across multiple dimensions align, confidence in the assessment increases; when signals diverge, it indicates a transitional or consolidation phase, helping to avoid being misled by a single indicator.

Technical Indicators

AI-GeneratedAs of October 8, 2026, **AUPH technical analysis** is starting to show cracks in near-term structure. The stock trades at 16.32, sitting just above the 50-day SMA \(16.0451\) but below the 20-day SMA, signaling early weakness in short-term momentum. The MACD level stands at -0.0948 with a sell signal, indicating that momentum drivers are fading rather than building. RSI at 44.31 sits in neutral territory, neither oversold nor overbought, but tilted toward cautionary rather than bullish. The positive note is that price remains above the 200-day SMA \(15.5544\), anchoring longer-term support. However, **AUPH price prediction** hinges on whether the stock can recapture the 20-day line; failure to do so risks a test of the 50-day and eventually the 200-day average. The MACD sell signal combined with price weakness relative to the 20-day SMA creates a near-term bearish lean. Watch for consolidation around the 16.00–16.32 zone or breakdown below the 50-day to confirm further deterioration.
IndicatorValueSignal
Exponential Moving Average (10)16.1848
Buy
Exponential Moving Average (100)15.945
Buy
Exponential Moving Average (20)16.2243
Buy
Exponential Moving Average (200)15.2416
Buy
Exponential Moving Average (30)16.2133
Buy
Exponential Moving Average (50)16.1496
Buy
Hull Moving Average (9)16.1927
Buy
Ichimoku Base Line (9, 26, 52, 26)16.3149
neutral
Moving Averages Summary—
neutral
Simple Moving Average (10)16.115
Buy
Simple Moving Average (100)16.0135
Buy
Simple Moving Average (20)16.3613
Buy
Simple Moving Average (200)15.5575
Buy
Simple Moving Average (30)16.2898
Buy
Simple Moving Average (50)16.0836
Buy
Volume Weighted Moving Average (20)16.3766
Buy
Average Directional Index (14)19.483
neutral
Awesome Oscillator-0.3784
neutral
Bull Bear Power0.3321
Buy
Commodity Channel Index (20)23.8596
neutral
MACD Level (12, 26)-0.0257
Sell
Momentum (10)0.155
Buy
Oscillators Summary—
neutral
Relative Strength Index (14)56.975
neutral
Stochastic %K (14, 3, 3)55.248
neutral
Stochastic RSI Fast (3, 3, 14, 14)66.7479
neutral
Ultimate Oscillator (7, 14, 28)61.0813
neutral
Williams Percent Range (14)-20.7746
neutral
Technical Summary—
neutral

Market Sentiment

AI-GeneratedNo data yet
Analyst Rating
17.8571
Options Put/Call Ratio
--
Implied Volatility (IV)
--

Market Structure

AI-GeneratedNo data yet
Float
129,100,879.0000
Short Ratio
0.0798
% Held by Institutions
0.6042

Influencing Factors

Corporate Earnings and Profit Growth

Revenue, net profit, and forward guidance are the core factors affecting stock prices.

Industry Competition Landscape and Market Share

Changes in a company's competitiveness within the industry and its market share will impact its long-term valuation.

Overall Market Valuation and Interest Rate Environment

When interest rates rise or overall market valuations are elevated, individual stocks are more likely to experience pullbacks.

Institutional Funds and Market Sentiment

Large-scale institutional inflows or outflows, along with changes in market risk appetite, can amplify stock price volatility.

FAQ

What data is used to generate the AUPH(Aurinia Pharmaceuticals) price prediction?

x

AUPH(Aurinia Pharmaceuticals) price prediction is typically based on three types of data: technical indicators (e.g., RSI, MACD, moving averages), market sentiment (e.g., capital flows and derivatives data), and market structure signals (e.g., positioning and supply-demand changes). Multi-dimensional data is used to enhance the completeness of the analysis.

How do supply and demand affect the AUPH(Aurinia Pharmaceuticals) price prediction?

x

How are technical indicators used in the AUPH(Aurinia Pharmaceuticals) price prediction?

x

What role does market sentiment play in the AUPH(Aurinia Pharmaceuticals) price prediction?

x

What common factors can influence the AUPH(Aurinia Pharmaceuticals) price prediction?

x

How can price predictions be used to assess the current market state of AUPH(Aurinia Pharmaceuticals)?

x

Disclaimer

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.

Risk Warning

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Disclosure.